Obinutuzumab plus bendamustine in rituximab-refractory indolent lymphoma Comment uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Hematopoietic Stem Cell Transplantation
  • Lymphoma

publication date

  • January 2016

Research

keywords

  • Comment

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(16)30157-7

Additional Document Info